ABIVAX: Publication of Capital and Voting Rights Data as of November 30, 2025

On December 12, 2025, ABIVAX, a biotechnology company, released figures relating to its share capital and voting rights. As of November 30, 2025, ABIVAX's share capital amounted to €779,033.23, comprised of 78,398,795 shares. The total number of theoretical and exercisable voting rights was 82,688,932.

This information is crucial for analyzing threshold crossings in accordance with the regulations of the French Financial Markets Authority (AMF). Theoretical voting rights include all shares, even those without voting rights, while exercisable voting rights focus on shares with active voting rights.